Ligand · B2D
B2D · 7-methoxy-N-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-1,5-naphthyridin-4-amine
B2D, 7-methoxy-N-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-1,5-naphthyridin-4-amine (C21 H17 N7 O, 383.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- B2D
- Formula
- C21 H17 N7 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
B2D in 2 structures; the first of them:
- 3I5N · Crystal structure of c-Met with triazolopyridazine inhibitor 13 · B2D A1 · binds ILE1084, GLY1085, VAL1092, ALA1108, LEU1140, LEU1157, PRO1158, TYR1159 and 12 more
- 3I5N · Crystal structure of C-met with triazolopyridazine inhibitor 13 · B2D A1 · binds ILE1084, GLY1085, VAL1092, ALA1108, LEU1140, LEU1157, PRO1158, TYR1159 and 12 more
Residues it binds most
ALA 2, ASN 2, ASP 2, GLY 2, LEU 2, MET 2, TYR 2, ARG 2, ILE 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.